Core Viewpoint - The report outlines the passive reduction of shares held by the controlling shareholder of Yuekang Pharmaceutical Group Co., Ltd. due to a judicial auction, resulting in a significant decrease in both the controlling shareholder's and the concerted parties' ownership percentages [38][40]. Group 1: Shareholding Changes - The controlling shareholder, Fuyang Jingyue Yongshun Information Consulting Co., Ltd., reduced its shareholding from 180,240,120 shares (40.05% of total shares) to 153,740,120 shares (34.16%) following the judicial auction of 26,500,000 shares [38][40]. - The total shares held by the controlling shareholder and its concerted parties decreased from 245,447,562 shares (54.54%) to 218,947,562 shares (48.66%) after the share reduction [38][40]. Group 2: Judicial Auction Details - The judicial auction took place from July 14 to July 15, 2025, where the 26,500,000 shares were sold entirely to 12 individual buyers [10][38]. - The auction was conducted on the JD.com judicial auction platform, and the shares were confirmed to have been transferred as per the court's execution ruling [10][11]. Group 3: Future Shareholding Plans - The controlling shareholder and its concerted parties do not rule out the possibility of further adjustments to their shareholdings within the next 12 months, depending on market conditions and their own circumstances [8][10]. - The report emphasizes that any future changes will comply with relevant laws and regulations regarding information disclosure [10][41]. Group 4: Impact on Company Control - The reduction in shareholding does not affect the stability of the company's control, as the remaining frozen shares do not pose a risk to the company's management [31][34]. - The controlling shareholder's remaining frozen shares amount to 5,670,654 shares, representing 1.26% of the total shares [32][34].
悦康药业集团股份有限公司 简式权益变动报告书